Observational studyArthritis research & therapy2024

Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study.

Jingbo Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.